In a lengthy statement revealing plans to strengthen the agency’s regulation of dietary supplements, FDA Commissioner Scott Gottlieb, M.D., expressed concern that “changes in the supplement market may have outpaced the evolution of our own policies and our capacity to manage emerging risks.”